Hutchin Hill Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$693K Sell
8,200
-8,500
-51% -$723K 0.19% 122
2017
Q3
$1.43M Buy
16,700
+100
+0.6% +$8.2K 0.05% 273
2017
Q2
$1.37M Sell
16,600
-45,300
-73% -$3.7M 0.05% 424
2017
Q1
$5.21M Buy
61,900
+38,900
+169% +$3.12M 0.14% 155
2016
Q4
$1.69M Buy
23,000
+19,600
+576% +$1.46M 0.06% 349
2016
Q3
$273K Buy
3,400
+300
+10% +$24K 0.01% 536
2016
Q2
$244K Sell
3,100
-10,700
-78% -$806K 0.01% 466
2016
Q1
$994K Buy
13,800
+6,000
+77% +$454K 0.03% 426
2015
Q4
$657K Buy
+7,800
New +$647K 0.02% 490
2014
Q1
Sell
-28,100
Closed -$1.43M 667
2013
Q4
$1.43M Sell
28,100
-100,800
-78% -$5.05M 0.1% 217
2013
Q3
$6.49M Buy
128,900
+78,900
+158% +$4.13M 0.59% 42
2013
Q2
$2.46M Buy
+50,000
New +$2.72M 0.25% 68

Other funds holding LLY

Hutchin Hill Capital's LLY Position: Q4 2017 in Review

Hutchin Hill Capital reduced its Eli Lilly (LLY) stake by 51% in Q4 2017, selling an estimated $723K and leaving 8,200 shares worth $693K. The position accounts for 0.19% of the portfolio, ranked #122.

Hutchin Hill Capital first reported a position in LLY in Q2 2013 and has held it in 12 quarters since. The position peaked at $6.49M in Q3 2013. 1,373 funds tracked by Wall St. Rank hold LLY as of Q4 2017.

  • Hutchin Hill Capital held 8,200 shares of Eli Lilly worth $693K as of Q4 2017.
  • Hutchin Hill Capital sold 8,500 Eli Lilly shares in Q4 2017, an estimated $723K.
  • Eli Lilly made up 0.19% of Hutchin Hill Capital's portfolio in Q4 2017, its #122 holding.
  • Hutchin Hill Capital first reported a position in Eli Lilly in Q2 2013 and has held it in 12 quarters since.
  • Hutchin Hill Capital's Eli Lilly position peaked at $6.49M in Q3 2013.
  • 1,373 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2017.

Based on Hutchin Hill Capital's 13F filing for Q4 2017, filed 12 Feb 2018.